logo
logo

Haemonetics Appoints Frank Chan As Executive Vice President, Chief Operating Officer; Roy Galvin As Executive Vice President, Chief Commercial Officer

Mar 03, 20256 months ago

Position

Chief Operating Officer

Company

Haemonetics

Frank Chan
BostonMedicalBiotechnology

Description

Haemonetics Corporation announced the appointment of Frank Chan, Ph.D. as Executive Vice President, Chief Operating Officer effective April 7, 2025, and the appointment of Roy Galvin as the company's Executive Vice President, Chief Commercial Officer, effective immediately.

Company Information

Company

Haemonetics

Location

Boston, Massachusetts, United States

About

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months